Price Target. $ (% upside). Analyst Consensus: Buy. Created with Highcharts Strong Sell Sell Hold Buy Strong Buy 0 2 4. Stock Forecasts. So BioCryst Pharmaceuticals, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes. Find the latest BioCryst Pharmaceuticals, Inc. (BCRX) stock quote 7 Small-Cap Stocks to Buy. BioCryst Pharmaceuticals currently has an average brokerage recommendation (ABR) of on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on. The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to its.
Track Biocryst Pharmaceuticals Inc. (BCRX) Stock Price, Quote, latest Do Not Sell or Share My Personal Data. When you visit our website, we store. Analyst Ratings. The average analyst rating for BCRX stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform. The consensus among 5 Wall Street analysts covering (NASDAQ: BCRX) stock is to Buy BCRX stock. Out of 5 analysts, 0 (0%) are recommending BCRX as a Strong Buy. Stockchase rating for BioCryst Pharmaceuticals is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the. View the real-time BCRX price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. BioCryst Pharmaceuticals has received a consensus rating of Moderate Buy. The company's average rating score is , and is based on 5 buy ratings, 1 hold. BioCryst Pharmaceuticals stock upgraded from Buy Candidate to Strong Buy Candidate after Wednesday trading session. (Updated on Aug 28, ) · BCRX Signals &. Get Wall Street analysts ratings for BioCryst Pharmaceuticals, Inc. (BCRX). Buy or Sell this stock? See what the analysts say. 2 Biotech Stocks You'll Regret Not Buying on the Dip BioCryst Pharmaceuticals and Intellia Therapeutics could storm back in the second half of Why. The current price BioCryst Pharma (BCRX) is trading at is $, which is out of the analyst's predicted range. Browse analyst ratings and price targets on all. Based on analysts offering 12 month price targets for BCRX in the last 3 months. The average price target is $ with a high estimate of $30 and a low.
Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. BCRX will report earnings. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A. Style Scorecard. The current price BioCryst Pharma (BCRX) is trading at is $, which is out of the analyst's predicted range. Browse analyst ratings and price targets on all. Buy. Overweight. 0. 0. Hold. 2. 1. Underweight. 0. 0. Sell. 0. 0. ConsensusBuyBuy. Stock Price Target. High, $ Low, $ Average, $ BioCryst Stock Smart Score ; Analyst Consensus. Strong Buy. Average Price Target: $ (% Upside) ; Blogger Sentiment. Bullish. BCRX Sentiment 95% Sector. Given the investment horizon of 90 days and your below-average risk tolerance, our recommendation regarding BioCryst Pharmaceuticals is 'Cautious Hold'. A buy. According to analysts, BCRX price target is USD with a max estimate of USD and a min estimate of USD. Find the latest BioCryst Pharmaceuticals, Inc. (BCRX) stock quote, history, news and other vital information to help you with your stock trading and. Is BioCryst Pharmaceuticals stock a Buy, Sell or Hold? BioCryst Pharmaceuticals stock has received a consensus rating of buy. The average rating score is.
Assess the BioCryst stock price estimates. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst Month BCRX. View BioCryst Pharmaceuticals, Inc. BCRX stock quote prices, financial information, real-time forecasts, and company news from CNN. Based on our BioCryst Pharmaceuticals stock forecast, BioCryst Pharmaceuticals stock is currently a good stock to buy. This is because the price of BioCryst. Wall Street Analysts See a % Upside in BioCryst (BCRX): Can the Stock Really Move This High? Zacks • am. The latest consensus rating for BCRX is "Buy". This is the average recommendation of 18 analysts: 0 strong sell, 0 sell, 3 hold, 11 buy, 4 strong buy. In.
TESLA Stock - Is This A TOP For TSLA Stock?
0. 0. 0. Hold. 0. 2. 1. Underweight. 0. 0. 0. Sell. 0. 0. 0. Consensus. -. Buy. Buy. Stock Price Target BCRX. High, $ Median, $ Low, $ Average. Strong Buy = 5 · Moderate Buy = 4 · Hold = 3 · Moderate Sell = 2 · Strong Sell = 1. BCRX Broker Recommendations Summary. Average Broker Rating, Strong Buy, Buy, Hold, Sell, Strong Sell, Analysts Issuing Recs. , 8, 2, 2, 0, 0, The Trend. quickly from buy to sell, just to return to buy). Stock Score. Buy Signals. Sell Signals. Bollinger Bands. Buy Signals. Sell Signals. MACD. Buy Signals. Sell. The stock price for BioCryst Pharma (NASDAQ: BCRX) is $ last updated September 6, at PM EDT. Q. Does BioCryst Pharma (BCRX) pay a dividend? A.